• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Nigeria fully digitized 38 MDAs, says civil service head
  • NCS urges better use of community sports facilities in Apapa
  • Nigeria launches N50m fund for cancer patients
  • Nigeria’s current account surplus jumps 256% to $4.98bn in Q1 2026
  • IWMI, IFPRI link Kano farmers to solar irrigation support
  • NCS urges border officers to prioritize safety
  • Keke riders protest police harassment in Warri
  • NEDC boosts healthcare in Adamawa
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    IWMI, IFPRI link Kano farmers to solar irrigation support

    June 17, 2026

    Dangote expects over $4bn annual forex earnings from fertiliser exports

    June 16, 2026

    AFAN Kano calls for fertilizer subsidy to boost agriculture

    June 16, 2026

    Food security expert urges youth involvement in agriculture

    June 16, 2026

    Jigawa farmers hope for bumper harvest

    June 15, 2026
  • Sci & Tech

    Nigeria fully digitized 38 MDAs, says civil service head

    June 17, 2026

    Anambra trains 480 in tech skills

    June 17, 2026

    Ericsson reports rapid growth in global 5G subscriptions

    June 16, 2026

    Musk predicts SpaceX could generate $1trn revenue by 2030

    June 15, 2026

    NCDMB trains 160 youths in AI, data analytics

    June 12, 2026
  • Health

    Nigeria launches N50m fund for cancer patients

    June 17, 2026

    NEDC boosts healthcare in Adamawa

    June 17, 2026

    Niger intensifies Ebola screening for returning pilgrims from Saudi Arabia

    June 17, 2026

    Two centuries of healing: How Sokoto’s legacy powered UDUTH’s breakthrough kidney transplant

    June 17, 2026

    Bauchi gov commends F4H for saving lives

    June 17, 2026
  • Environment

    GlobalFact summit brings 500 fact-checkers from 80 countries to Lithuania

    June 17, 2026

    All injured passengers discharged after train accident

    June 16, 2026

    SWEEP calls for waste management reforms in Lagos

    June 16, 2026

    Chairman pledges continued crackdowns on criminal hideouts

    June 16, 2026

    ACR calls for national honor for plastic bottle house pioneer

    June 15, 2026
  • Hausa News

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025

    [BIDIYO] Yadda na lashe gasa ta duniya a fannin Ingilishi – Rukayya ‘yar shekara 17

    August 6, 2025

    A Saka Baki, A Sasanta Saɓani Tsakanin ‘Yanjarida Da Liman, Daga Muhammad Sajo

    May 21, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    Nigeria fully digitized 38 MDAs, says civil service head

    June 17, 2026

    NCS urges better use of community sports facilities in Apapa

    June 17, 2026

    Nigeria launches N50m fund for cancer patients

    June 17, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Nigeria fully digitized 38 MDAs, says civil service head

    June 17, 2026

    NCS urges better use of community sports facilities in Apapa

    June 17, 2026

    Nigeria launches N50m fund for cancer patients

    June 17, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»[EXPLAINER] What is Amlodpine, the famous antihypertensive?
Health & Healthy Living

[EXPLAINER] What is Amlodpine, the famous antihypertensive?

Abdallah el-KurebeBy Abdallah el-KurebeFebruary 3, 2025Updated:February 4, 2025No Comments3 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email

Amlodipine is one of the most widely used blood pressure medications. But why do doctors prescribe it so often? Let’s break it down.

What is Amlodipine?

Amlodipine is an oral dihydropyridine Calcium Channel blocker used in the treatment of heart diseases.

For context, calcium channel blockers (CCBs), are a class of antihypertensives, divided into:

  • Dihyropyridines
  • Non-dihydropyridines

What is their mechanism of action?

Calcium channel blockers work by blocking voltage dependent L-type calcium channels in the heart, blood vessels and pancreas.

These channels regulate calcium influx into muscle cells, and with reduced calcium, the muscles relax, and the blood vessels open up.

This leads to a reduction in blood pressure, and improved blood flow.

Why is Amlodipine different?

  • Unlike other CCBs, Amlodipine has a half-life of 30-50 hours, making it suitable as a once-daily dosing.
  • It has strong blood pressure lowering effects, and works for all age groups.
  • It is safe for patients with other conditions like chronic kidney disease, diabetes and asthma.
  • It can be combined with other blood pressure medications for better blood pressure control.
  • It is affordable and highly available.
  • Additionally, it is well tolerated by blacks and elderly people (little side effects), making it a universal drug of choice.

What conditions doest it treat?

It is used in treating:

  • Hypertension: It lowers blood pressure and reduces risk of complications
  • Angina (Chest pain): It improves blood flow and supply to the heart
  • Coronary artery disease.

Off-label, it can be used for:

  • Diabetic nephropathy
  • Raynaud’s phenomenon
  • Silent myocardial ischemia
  • Left ventricular hypertrophy

How to take Amlodipine

  • Amlodipine is available in 2.5mg, 5mg and 10mg tablets.
  • It is mostly started as a 5mg once daily dosing, and maintained as a 10mg dosing.
  • It can be taken with or without food, and at the same time everyday.

NB: Do not stop amlodipine suddenly as it may cause a spike in blood pressure.

What are the side effects?

Common side effects include:

  • Swelling in the feet and ankles
  • Dizziness or Lightheadedness
  • Headache
  • Nausea
  • Fatigue

If you experience severe side effects, please seek medical attention immediately.

Who should avoid Amlodipine?

  • People with hypotension
  • Those allergic to Amlodipine
  • Patients with advanced heart failure
  • Those with severe liver disease.

For better blood pressure control, amlodipine is often combined with other blood pressure medications.

However, it’s important not to overdose on it, because it leads to severe hypotension.

Amlodipine is universally prescribed because it is effective, safe, long-acting, well tolerated and affordable.

It works for most patients with hypertension, angina and coronary artery disease, making it a first line treatment worldwide.

By Pharm. Uluoma @zizelle_

Amlodpine Hypertension
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Abdallah el-Kurebe
  • Website
  • Facebook
  • Twitter
  • LinkedIn

Related Posts

Nigeria launches N50m fund for cancer patients

June 17, 2026

NEDC boosts healthcare in Adamawa

June 17, 2026

Niger intensifies Ebola screening for returning pilgrims from Saudi Arabia

June 17, 2026

Leave A Reply Cancel Reply

Nigeria fully digitized 38 MDAs, says civil service head

June 17, 2026

NCS urges better use of community sports facilities in Apapa

June 17, 2026

Nigeria launches N50m fund for cancer patients

June 17, 2026

Nigeria’s current account surplus jumps 256% to $4.98bn in Q1 2026

June 17, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.